Primary Liver Cancer
Conditions
Interventions
Jiedu Granules:Jiedu Granules
Control Group:Basic treatment
Sponsors
Shanghai Changhai Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 79 Years
Inclusion criteria
Inclusion criteria: (1) Primary liver cancer patients diagnosed according to the criteria for diagnosis and treatment of primary liver cancer (2017 edition); (2) Patients should not receive any Chinese herbal medicine or systemic treatment in the past two weeks; (3) ECOG (Eastern Cooperative Oncology Group) score 0-1; (4) Compensatory liver function, or Child-Pugh grade A or B; (5) The patient needs at least 3 months of life expectancy; (6) Voluntarily to accept the treatment of the study protocol and sign the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Taking other drugs that may affect the evaluation of observational indicators during the trial period; (2) The Child-Pugh score of liver function was grade C; (3) WBC <2.0×10^9/L, platelets <30×10^9/L; (4) The ratio of tumors to whole liver is greater than 70%; (5) Combining severe primary diseases such as cardiovascular, hepatic, renal and hematopoietic diseases and psychotic patients; (6) The enrolled patients do not use treatment drugs according to our project, or it is impossible to judge the curative effect, or incomplete data, etc. that affect the efficacy judgment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Inflammatory factors; | — |
Secondary
| Measure | Time frame |
|---|---|
| Liver function;Routine blood test; | — |
Countries
China
Contacts
Public ContactBinbin Cheng
Shanghai Changhai Hospital
Outcome results
None listed